Efficacy of three filgrastim-intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico.
Andrés Gómez-De LeónEmmanuel BugarinPerla R Colunga-PedrazaJulia E Colunga-PedrazaRosario Salazar-RiojasMayra Valdés-GalvánYadith K López-GarcíaMariana López-GarzaCésar H Gutiérrez-AguirreOlga G Cantú-RodríguezConsuelo Mancías-GuerraOscar González-LlanoDavid Gómez-AlmaguerPublished in: Journal of clinical apheresis (2019)
In conclusion, three FICs available in Mexico were efficacious and without immediate severe adverse effects, resulting in significant cost savings. Evaluation of immunogenicity and establishment of a pharmacovigilance program with the use of FICs is warranted.